{
  "id": 20631257,
  "title": "Cerebras Systems vs. IonQ: Which Technology Stock Is a Better Buy for 2027?",
  "url": "https://urgent.news/2026/11/18/cerebras-systems-vs-ionq-which-technology-stock-is-a-better-buy-for",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-18T17:45:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/better-buy/2026/11/18/cerebras-systems-vs-ionq-which-technology-stock-is-a-better-buy-for-2027/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "The tech industry faces a competition between established AI hardware firms and cutting-edge quantum computing companies. Two such companies are Cerebras Systems (CBRS -5.68%) and IonQ (IONQ -3.10%). Cerebras creates massive silicon wafers to boost current AI workloads, while IonQ builds quantum systems for problems beyond traditional chips. Both companies are scaling rapidly but face different financial and competitive challenges. Investors must weigh current AI demand against long-term quantum breakthroughs.\n\nCerebras Systems offers AI compute systems with its Wafer-Scale Engine, the largest processor ever built for high-performance computing. It sells these on-premises and through cloud access, targeting sectors like medical research, cryptography, and energy. The company has grown significantly, with revenue reaching nearly $510.0 million in the fiscal year ended Dec. 31, 2025, a 75.7% increase over the prior year. However, it reported a net income of $237.8 million and a net margin of 46.6%.\n\nOn the other hand, IonQ specializes in trapped-ion quantum computing, providing access to its systems through major cloud providers and proprietary networking solutions. Its customer base includes defense and logistics sectors, requiring high-performance hardware for complex simulations. IonQ's revenue increased by 201.9% to nearly $130.0 million in the fiscal year ended Dec. 31, 2025, but it reported a net loss of $510.4 million and a net margin of -392.6%.\n\nWhen comparing these two companies, both exhibit impressive growth rates, but IonQ edges out Cerebras in terms of revenue growth and valuation. IonQ's net cash of $0.9 billion is significantly higher than Cerebras' $6.4 billion, giving IonQ a deeper cash cushion for stable growth. Valuation-wise, IonQ's price-to-sales ratio of 23.6x is slightly lower than Cerebras' 29.6x, making its shares more affordable. Despite the significant risks due to lack of profitability, IonQ's higher growth rate and lower valuation make it the more attractive buy for 2027.",
  "summary": "Cerebras trades at 81.4x forward earnings while IonQ commands 302.3x, a gap that reframes how much risk each stock really carries.",
  "key_points": [
    "Cerebras Systems creates massive silicon wafers for AI workloads",
    "IonQ builds quantum systems for problems beyond traditional chips",
    "IonQ shows higher growth rate and lower valuation than Cerebras"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}